Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iatrogenic Atrial Septal Defect Study

NCT04395027 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04395027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04395027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iatrogenic Atrial Septal Defect Study
Lead sponsor
Henry Ford Health System
Phase
Phase 3
Overall status
Withdrawn
Start date
May 6, 2020
Completion date
March 22, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septal defect, atrial